Latest Breaking News On - Potential multi target - Page 1 : comparemela.com

15.02.2022 - Completed acquisition of BayMedica, a rare cannabinoid manufacturing and commercialization company in the health and wellness sectorStrengthened IP with patent filing for use of rare cannabinoids for the treatment of neurodegenerative .

United kingdomInmed baymedicaCatherine sazdanoffColin clancyErica adamsWilliam garnerInmed pharmaceuticalsPartner at norton rose fulbright canadaDrug administrationCompensation committeeBaymedica incAudit committeeExchange commissionDevelopment programsAlmac group united kingdomAssurance standards council of canada